Mount Sinai Medical CenterNew York, NY
19 - Phase 3, Double-Blind, Randomized STARS Trial of Apraglutide Once-Weekly in Patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF): Subgroup Analyses by Baseline Demographics and SBS Disease Characteristics
Tuesday, October 29, 20248:30 AM – 8:40 AM ET